Packages of top drug brands to have QR codes from todayThe National Pharmaceuticals Pricing Authority (NPPA) had last year identified brands including Dolo, Saridon Fabiflu, Ecosprin, Limcee, Su...
We continuously evolve and believe that every successful formula has an expiry date, says Mankind Pharma’s Rajeev JunejaMankind Pharma's IPO will open on April 25. Rajeev Juneja, VC & MD, shares the company's journey from starting with an initial capital of R...
Govt shortlists top 300 drug brands to introduce QR codesThe brands identified by the National Pharmaceuticals Pricing Authority (NPPA) include Dolo, Saridon Fabiflu, Ecosprin, Limcee, Sumo, Calpo...
Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drugUnder the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary li...
Mankind Pharma launches COVID protection policy to support families of deceased employeesUnder the COVID Protection Policy, the company will contribute an amount equivalent to five years of the last drawn gross annual salary to ...
Apax Partners, Carlyle front-runners for Mankind Pharma stake saleApax Partners & Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two s...
Mankind Pharma looking to sell 15 per cent stake; PE funds make a bee-lineMankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.
How Ramesh Juneja's Mankind Pharma has changed pharma game with pulp marketingMankind Pharma's strategy is to go after the masses with products they can afford, demolishing the margins of giant pharma cos.
- Stocks to watch: Uttam Galva, Tata Steel, Bayer Cropscience, Piramal Healthcare...
The world's largest steel maker ArcelorMittal is understood to be jointly working with its domestic partner Uttam Galva for setting up a Rs...
- Pharma cos oppose DCGI's ban on emergency contraceptive pill ads
Cos say the move contradicts government's health policies besides hurting their investments.
- Unwanted 72, i-pill makers get notice over ads
The Drug Controller General Of India (DCGI) has issued showcause notices to Piramal Healthcare, Mankind Pharma and Morepen Laboratories for...
- Piramal buys Cipla's i-pill for Rs 95 crore
Piramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter...
- Govt mulls banning emergency contraceptive pills ads
It could be curtains down for advertisements of controversial emergency contraceptive pills (ECPs) such as Cipla’s i-pill and Mankind Pharm...
- Govt plans new norms for ads on emergency contraceptive pills
The government has decided to frame guidelines on advertisements of emergency contraceptive pills (ECP) to ensure consumers be aware of the...
- Most enamel paints have unacceptable amounts of lead: Study
Most of the popular brands of enamel paints used in homes contain unacceptable amounts of lead, a toxin that can cause neurological damage ...
- Morning after, men try to find what's i-pill
Pharma major Cipla's toll-free helpline number on emergency contraceptives receives 300 calls per day, a good 40% of them from men. Investo...
- AI-Indian merger after staff comes on board
The empowered group of ministers (eGoM) on merger of public sector carriers Air India (AI) and Indian has asked the civil aviation ministry...